<DOC>
	<DOCNO>NCT00278278</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy work different way stop growth tumor cell , either kill cell stop divide . Giving one drug ( combination chemotherapy ) may kill tumor cell . Radiation therapy use high-energy x-ray kill tumor cell . It yet know whether give methotrexate together combination chemotherapy radiation therapy effective combination chemotherapy radiation therapy alone treat glioma . PURPOSE : This randomized phase III trial study give methotrexate together combination chemotherapy radiation therapy see well work compare combination chemotherapy radiation therapy alone treat young patient newly diagnose glioma .</brief_summary>
	<brief_title>Combination Chemotherapy Radiation Therapy With Without Methotrexate Treating Young Patients With Newly Diagnosed Gliomas</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine addition high-dose methotrexate prior standard treatment improve survival patient malignant high-grade glioma diffuse intrinsic pontine glioma compare standard treatment . Secondary - Determine addition high-dose methotrexate , compare standard treatment , improve tumor response patient . - Determine high-dose methotrexate , compare standard treatment , improve progression-free event-free survival patient . - Determine high-dose methotrexate , compare standard treatment , improve health status ( quality life ) patient . - Determine consolidation therapy improve overall , progression-free , event-free survival rate compare historical control group . OUTLINE : This randomize , open-label , multicenter study . Patients stratify accord tumor location include pons ( yes v ) complete nearly complete resection ( yes v ) . - Surgery : All patient encourage undergo radical resection tumor reduce intracranial pressure , remove much tumor tissue possible , obtain tumor tissue histological diagnosis . Within 14 day surgery , patient proceed induction chemotherapy . - Induction therapy : Patients randomize 1 2 treatment arm . - Arm I : - High-dose methotrexate leucovorin calcium : Patients receive high-dose methotrexate IV 24 hour day 1 15 leucovorin calcium IV every 6 hour day 2-3 16-17 . Patients proceed chemoradiotherapy 4 week later . - Chemoradiotherapy ( course 1 ) : Patients undergo external beam radiotherapy daily , 5 day week , approximately 6 week . Beginning first day radiotherapy , patient receive cisplatin IV 1 hour day 1-5 , etoposide IV 2 hour day 1-3 , vincristine IV day 5 , 12 , 19 , 26 , 33 . Patients proceed course 2 chemoradiotherapy 7 day prior completion radiotherapy . - Chemoradiotherapy ( course 2 ) : Patients receive ifosfamide IV 1 hour cisplatin IV 1 hour day 1-5 , etoposide IV 2 hour day 1-3 , vincristine IV day 5 . Patients proceed consolidation chemotherapy 4 week later . - Arm II : Patients receive chemoradiotherapy course 1 2 arm I proceed consolidation chemotherapy 4 week later . - Consolidation chemotherapy : Patients receive vincristine IV day 1 , 8 , 15 , oral lomustine day 2 , oral prednisone daily day 1-17 . Treatment repeat every 6 week 8 course . Quality life assess 1 week surgery , completion chemoradiotherapy , 1 , 4 , 13 month completion consolidation chemotherapy , annually 3 year . After completion study treatment , patient follow periodically 3 year . PROJECTED ACCRUAL : A total 150 patient accrue study .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Isophosphamide mustard</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<mesh_term>Lomustine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Newly diagnose tumor brain spinal cord , meet one follow criterion : Histologically* confirm diagnosis 1 follow highgrade glioma : Glioblastoma ( WHOº IV ) Anaplastic astrocytoma ( WHOº III ) Gliosarcoma ( WHOº III IV ) Anaplastic oligoastrocytoma NOTE : *Histological requirement may waive type brainstem glioma Radiologically proven diffuse intrinsic pontine glioma Second malignancy disseminate metastasis multifocal tumor allow field irradiation large No diffuse metastases make craniospinal irradiation necessary PATIENT CHARACTERISTICS : No cardiorespiratory insufficiency require medical respiration No low blood pressure require systemic catecholamine No severe neurological damage ( e.g. , coma ) No tetraplegia without possibility communicate No poor clinical condition Not pregnant Fertile patient must use effective contraception No hypersensitivity methotrexate , cisplatin , vincristine , lomustine , ifosfamide No malignancy precede radiotherapy allow radiation PRIOR CONCURRENT THERAPY : No prior chemotherapy brain tumor The following prior therapy allow : Mistletoe H15 ( extract Boswellia serrata ) Homeopathy therapy dilution &gt; 4D Alternative medicine without proven efficacy No prior radiotherapy brain tumor No concurrent alcohol tobacco consumption No concurrent participation another study</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>untreated childhood brain stem glioma</keyword>
	<keyword>untreated childhood cerebellar astrocytoma</keyword>
	<keyword>childhood high-grade cerebral astrocytoma</keyword>
	<keyword>childhood spinal cord neoplasm</keyword>
</DOC>